The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions
Open accessAbstract
Serological tests for antibodies specific for Epstein-Barr virus (EBV) antigens are frequently used to define infection status and for the differential diagnosis of other pathogens responsible for mononucleosis syndrome. Using only three parameters [viral capsid antigen (VCA) IgG, VCA IgM and EBV nuclear antigen (EBNA)-1 IgG],it is normally possible to distinguish acute from past infection: the presence of VCA IgM and VCA IgG without EBNA-1 IgG indicates acute infection, whereas the presence of VCA IgG and EBNA-1 IgG without VCA IgM is typical of past infection. However, serological findings may sometimes be difficult to interpret as VCA IgG can be present without VCA IgM or EBNA-1 IgG in cases of acute or past infection, or all the three parameters may be detected simultaneously in the case of recent infection or during the course of reactivation. A profile of isolated EBNA-1 IgG may also create some doubts. In order to interpret these patterns correctly, it is necessary to determine IgG avidity, identify anti-EBV IgG and IgM antibodies by immunoblotting, and look for heterophile antibodies, anti-EA (D) antibodies or viral genome using molecular biology methods. These tests make it possible to define the status of the infection and solve any problems that may arise in routine laboratory practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
Reedman, B. M., & Klein, G. (1973) · International Journal of Cancer · doi:10.1002/ijc.2910110302 · Cited by 1,668
Epstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
Immunofluorescence in Cells Derived from Burkitt's Lymphoma
Henle, G., & Henle, W. (1966) · Journal of Bacteriology · doi:10.1128/jb.91.3.1248-1256.1966 · Cited by 1,439
(1948) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1948.tb28186.x · Cited by 1,141
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A., & Fearon, D. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4510 · Cited by 939
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892
(15031584), Y. M. D. L., Chan, L. Y. S., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T. �., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 777
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay
Kimura, H., Morita, M., Yabuta, Y., Kuzushima, K., Kato, K., Kojima, S., Matsuyama, T., & Morishima, T. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.1.132-136.1999 · Cited by 577
Tierney, R. J., Steven, N., Young, L. S., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7374-7385.1994 · Cited by 482
Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management
Straus, S. E., Cohen, J. I., Tosato, G., & Meier, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-1-199301010-00009 · Cited by 414
Lo, Y. M. D., Chan, L. Y. S., Chan, A. T. �., Leung, S. F., Lo, K. W., Zhang, J., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 390
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro
Rosén, A., Gergely, P., Jondal, M., Klein, G., & Britton, S. (1977) · Nature · doi:10.1038/267052a0 · Cited by 377
Epstein-Barr virus—recent advances
Macsween, K. F., & Crawford, D. H. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00543-7 · Cited by 344
A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals
Yao, Q. Y., Rickinson, A. B., & Epstein, M. A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350107 · Cited by 338
Laboratory Assays for Epstein-Barr Virus-Related Disease
Gulley, M. L., & Tang, W. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080023 · Cited by 324
Association between clinical disease activity and Epstein–Barr virus reactivation in MS
Wandinger, K.-P., Jabs, W., Siekhaus, A., Bubel, S., Trillenberg, P., Wagner, H.-J., Wessel, K., Kirchner, H., & Hennig, H. (2000) · Neurology · doi:10.1212/wnl.55.2.178 · Cited by 302
Chan, K. C. A., Zhang, J., Chan, A. T. �., Lei, K. I. K., Leung, S. F., Chan, L. Y. S., Chow, K. C., & Lo, Y. M. D. (2003) · PubMed · Cited by 251
Hess, R. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3381-3387.2004 · Cited by 232
Wagner, H.-J., Wessel, M., Jabs, W., Smets, F., Fischer, L., Offner, G., & Bucsky, P. (2001) · Transplantation · doi:10.1097/00007890-200109270-00006 · Cited by 218
Henle, W., Henle, G., Andersson, J., Ernberg, I., Klein, G., Horwitz, C. A., Marklund, G., Rymo, L., Wellinder, C., & Straus, S. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.570 · Cited by 207
Balfour, Jr., Holman, C. J., Hokanson, K. M., Lelonek, M. M., Giesbrecht, J. E., White, D. R., Schmeling, D. O., Webb, C., Cavert, W., Wang, D. H., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/491740 · Cited by 200
Long‐Term Shedding of Infectious Epstein‐Barr Virus after Infectious Mononucleosis
Fafi‐Kremer, S., Morand, P., Brion, J., Pavese, P., Baccard, M., Germi, R., Genoulaz, O., Nicod, S., Jolivet, M., Ruigrok, R. W. H., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428097 · Cited by 174
Kimura, H., Ito, Y., Suzuki, R., & Nishiyama, Y. (2008) · Reviews in Medical Virology · doi:10.1002/rmv.582 · Cited by 163
Stepwise intraclonal maturation of antibody affinity through somatic hypermutation.
Kocks, C., & Rajewsky, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8206 · Cited by 161
Epstein‐Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis
Larsen, P. D., Bloomer, L. C., & Bray, P. F. (1985) · Neurology · doi:10.1212/wnl.35.3.435 · Cited by 138
Hayden, R. T., Hokanson, K. M., Pounds, S. B., Bankowski, M. J., Belzer, S. W., Carr, J., Diorio, D., Forman, M., Joshi, Y., Hillyard, D. R., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01252-07 · Cited by 138
Yamamoto, M., Kimura, H., Hironaka, T., Hirai, K., Hasegawa, S., Kuzushima, K., Shibata, M., & Morishima, T. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.7.1765-1768.1995 · Cited by 133
Werblin, T. P., Kim, Y. T., Quagliata, F., et al. (1973) · PubMed · Cited by 132
Evidence-Based Approach for Interpretation of Epstein-Barr Virus Serological Patterns
Klutts, J. S., Ford, B. A., Perez, N. R., & Gronowski, A. M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00164-09 · Cited by 132
Sumaya, C. V., & Ench, Y. (1985) · PubMed · Cited by 127
Epstein-Barr Virus Infectious Mononucleosis in Children
Sumaya, C. V., & Ench, Y. (1985) · PEDIATRICS · doi:10.1542/peds.75.6.1011 · Cited by 119
Evans, A. S., & Niederman, J. C. (1982) · Springer eBooks · doi:10.1007/978-1-4613-3237-4_10 · Cited by 99
Niedobitek, G., Hamilton-Dutoit, S. J., Herbst, H., Finn, T., Vetner, M., Pallesen, G., & Stein, H. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90075-0 · Cited by 97
Epstein-Barr Virus (EBV) DNA in Plasma Is Not Encapsidated in Patients With EBV-Related Malignancies
Ryan, J. L., Fan, H., Swinnen, L. J., Schichman, S. A., Raab‐Traub, N., Covington, M., Elmore, S., & Gulley, M. L. (2004) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200406000-00001 · Cited by 90
Dynamics of Epstein‐Barr virus DNA levels in serum during EBV‐associated disease
Berger, C., Day, P. J., Meier, G., Zingg, W., Bossart, W., & Nadal, D. (2001) · Journal of Medical Virology · doi:10.1002/jmv.1078 · Cited by 89
Detection of Cell-Free Epstein-Barr Virus DNA in Serum during Acute Infectious Mononucleosis
Gan, Y.-J., Sullivan, J. L., & Sixbey, J. W. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.436 · Cited by 88
Robertson, P., Beynon, S., Whybin, L. R., Brennan, C. M., Vollmer-Conna, U. S., Hickie, I. B., & Lloyd, A. R. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10439 · Cited by 79
Gärtner, B. C., Hess, R. D., Bandt, D., Kruse, A., Rethwilm, A., Roemer, K., & Mueller‐Lantzsch, N. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.78-82.2003 · Cited by 72
Evaluation of Four Commercial Systems for the Diagnosis of Epstein-Barr Virus Primary Infections
de Ory, F., Guisasola, M. E., Sanz, J. C., & García-Bermejo, I. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00486-10 · Cited by 56
Seroepidemiology of EBV and interpretation of the “isolated VCA IgG” pattern
Paschale, M. D., Agrappi, C., Manco, M. T., Mirri, P., Viganò, E. F., & Clerici, P. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21373 · Cited by 53
Detection of Herpesvirus DNA in the Serum of Immunocompetent Children
Hara, S., Kimura, H., Hoshino, Y., Tanaka, N., Nishikawa, K., Ihira, M., Yoshikawa, T., & Morishima, T. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02683.x · Cited by 47
The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers
Paoli, P. D., Pratesi, C., & Bortolin, M. T. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0281-2 · Cited by 24
Ikuta, K., Saiga, K., Deguchi, M., & Sairenji, T. (2003) · Virus Genes · doi:10.1023/a:1023487413912 · Cited by 9
Cited by
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049
Epstein-Barr Virus and Systemic Autoimmune Diseases
Houen, G., & Trier, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587380 · Cited by 379
Smatti, M. K., Al-Sadeq, D. W., Ali, N. H., Pintus, G., Abou-Saleh, H., & Nasrallah, G. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00211 · Cited by 309
Uher, T., McComb, M., Galkin, S., Srpova, B., Oechtering, J., Barro, C., Tyblova, M., Bergsland, N., Krasensky, J., Dwyer, M., et al. (2021) · Multiple Sclerosis Journal · doi:10.1177/1352458520912379 · Cited by 86
Neurology of Acute Viral Infections
Krett, J. D., Beckham, J. D., Tyler, K. L., Piquet, A. L., Chauhan, L., Wallace, C. J., Pastula, D. M., & Kapadia, R. K. (2022) · The Neurohospitalist · doi:10.1177/19418744221104778 · Cited by 13
Metadata
- Authors
- De Paschale, M.
- Venue
- World Journal of Virology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2012
- Volume
- 1
- Issue
- 1
- Pages
- 31
- ISSN
- 2220-3249 (ISSN-L)
- OpenAlex
- W60157933
- Cited by
- 333
- References
- 47
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.